Resources
- AstraZeneca/Oxford vaccine more effective with longer dose gap: study
- EEOC guidance: Yes, employers can require the COVID-19 vaccine
- What is an employer's role in addressing vaccine hesitancy and accelerating the path back to the new normal?
- AZD1222 Oxford Phase III trials interim analysis results published in The Lancet
- Oxford Covid vaccine 'safe and effective' study shows
- Oxford-AstraZeneca vaccine is safe and effective, researchers confirm in peer-reviewed study
- Oxford-AstraZeneca Vaccine Effective But Questions Remain for Elderly
- Oxford–AstraZeneca COVID-19 vaccine efficacy
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- Covid vaccines cut risk of serious illness by 80% in over-80s
- Oxford says vaccine could curb not only illness, but spread of COVID-19
- One of the strongest weapons against COVID-19 variants may be a vaccine the FDA hasn't approved yet
- Covid: WHO backs Oxford vaccine 'even if variants present'
